Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | E-EDV-D682 |
| Trade Name | |
| Synonyms | E-EDV D682|E-EDVD682|Ep-EDV-682 |
| Drug Descriptions |
E-EDV-D682 is an antibody-nanocell conjugate, which delivers the cytotoxic drug PNU-159682 to tumor cells expressing EGFR, potentially resulting in inhibition of tumor growth (PMID: 32183951, PMID: 39373598). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| E-EDV-D682 | E-EDV-D682 | 0 | 0 |
| E-EDV-D682 + EDV-GC | E-EDV-D682 EDV-GC | 0 | 0 |
| E-EDV-D682 + EDV-GC + Gemcitabine + Nab-paclitaxel | E-EDV-D682 EDV-GC Gemcitabine Nab-paclitaxel | 0 | 1 |